These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1119803)

  • 21. Phosphoglycerate kinase of Bacillus stearothermophilus.
    Suzuki K; Imahori K
    J Biochem; 1974 Oct; 76(4):771-82. PubMed ID: 4436288
    [No Abstract]   [Full Text] [Related]  

  • 22. Recommended methods for the characterization of red cell pyruvate kinase variants. International Committee for Standardization in Haematology.
    Br J Haematol; 1979 Oct; 43(2):275-86. PubMed ID: 41566
    [No Abstract]   [Full Text] [Related]  

  • 23. Non-osmotic swelling in purified bovine myelin.
    McIlwain DL
    Brain Res; 1973 Mar; 52():97-113. PubMed ID: 4573430
    [No Abstract]   [Full Text] [Related]  

  • 24. Activation of human erythrocyte pyruvate kinase by hexose-bisphosphates.
    Badwey JA; Westhead EW
    Biochem Biophys Res Commun; 1977 Jul; 77(1):275-81. PubMed ID: 883978
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of Na+ and K+ on glycolytic enzymes: differential response of pyruvate kinase from dog and human erythrocytes.
    Bashan N; Moses S; Gross Y; Livine A
    FEBS Lett; 1975 Jul; 54(3):323-6. PubMed ID: 124266
    [No Abstract]   [Full Text] [Related]  

  • 26. [Studies on erythrocyte pyruvate kinase. I. Some properties of the normal human enzyme].
    Boivin P; Galand C; Demartial MC
    Pathol Biol (Paris); 1972; 20(11):583-94. PubMed ID: 4558576
    [No Abstract]   [Full Text] [Related]  

  • 27. Activation and inhibition of human erythrocyte pyruvate kinase by organic phosphates, amino acids, peptides and anions.
    Black JA; Henderson MH
    Biochim Biophys Acta; 1972 Sep; 284(1):115-27. PubMed ID: 4672508
    [No Abstract]   [Full Text] [Related]  

  • 28. Post-translational modification of human erythrocyte pyruvate kinase.
    Badwey JA; Westhead EW
    Biochem Biophys Res Commun; 1977 Feb; 74(4):1326-31. PubMed ID: 843365
    [No Abstract]   [Full Text] [Related]  

  • 29. Evidence for molecular alteration of pyruvate kinase as a consequence of erythrocyte aging.
    Paglia DE; Valentine WN
    J Lab Clin Med; 1970 Aug; 76(2):202-12. PubMed ID: 5434001
    [No Abstract]   [Full Text] [Related]  

  • 30. Phosphorylation of human erythrocyte pyruvate kinase by soluble cyclic-AMP-dependent protein kinases. Comparison with human liver L-type enzyme.
    Marie J; Buc H; Simon MP; Kahn A
    Eur J Biochem; 1980; 108(1):251-60. PubMed ID: 6250830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Characterization of the catalase of erythrocytes of a patient with the symptoms of Takahara's disease].
    Gross J; Scherz B; Wyss S; Künzel W; Maiwald HJ; Hartwig A; Polster H
    Acta Biol Med Ger; 1977; 36(5-6):793-5. PubMed ID: 602583
    [No Abstract]   [Full Text] [Related]  

  • 32. Proteolytic processing of human L-type pyruvate kinase increases its ability to be phosphorylated.
    Marie J; Kahn A
    Biochem Biophys Res Commun; 1980 Jun; 94(4):1387-93. PubMed ID: 7396967
    [No Abstract]   [Full Text] [Related]  

  • 33. Acquired pyruvate kinase deficiency. The effect of maleic acid upon human erythrocyte pyruvate kinase.
    Sprengers ED; Staal GE
    Clin Chim Acta; 1979 Aug; 96(1-2):79-83. PubMed ID: 476961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aspartate aminotransferase and pyruvate kinase activities in erythrocytes separated according to age by gradient centrifugation.
    Reverberi R; Ferrari L; Ferrari R; Galluccio L; Moretti M; Menini C
    Haematologica; 1986; 71(1):13-6. PubMed ID: 3084349
    [No Abstract]   [Full Text] [Related]  

  • 35. Identification of mutants of pyruvate kinase from red blood cells by means of trypsinization, electrophoresis, kinetic properties and immunological methods.
    Jacobasch G; Schulz J; Zanev D; Richter A; Gerth C; Plonka A
    Acta Biol Med Ger; 1981; 40(4-5):547-53. PubMed ID: 7315101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous, cyclic 3'-5' AMP-dependent phosphorylation of human red cell pyruvate kinase.
    Marie J; Tichonicky L; Dreyfus JC; Kahn A
    Biochem Biophys Res Commun; 1979 Apr; 87(3):862-8. PubMed ID: 222274
    [No Abstract]   [Full Text] [Related]  

  • 37. On the stability of bovine superoxide dismutase. The effects of metals.
    Forman HJ; Fridovich I
    J Biol Chem; 1973 Apr; 248(8):2645-9. PubMed ID: 4697386
    [No Abstract]   [Full Text] [Related]  

  • 38. Pyruvate kinase in human erythrocytes.
    Hanel HK
    Scand J Haematol; 1969; 6(3):173-4. PubMed ID: 5804718
    [No Abstract]   [Full Text] [Related]  

  • 39. Retention of trypsin and chymotrypsin proteolytic activity in sodium dodecyl sulfate solutions.
    Porter WH; Preston JL
    Anal Biochem; 1975 May; 66(1):69-77. PubMed ID: 1147220
    [No Abstract]   [Full Text] [Related]  

  • 40. Pyruvate kinase activity and response to allosteric effectors in rat erythrocytes and reticulocytes fractionated by multiple partitioning in aqueous two-phase systems.
    Pinilla M; Rodriguez-Horche P; Luque J
    Cell Biochem Funct; 1987 Oct; 5(4):301-7. PubMed ID: 3677327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.